These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Washington
|
91-0849125
|
|
(State of Incorporation)
|
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
x
|
|
|
|
|
|
|||
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
|
|
Page No.
|
|
|
|
|
|
PART I.
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
8-14
|
|
|
|
|
|
|
Item 2.
|
15-26
|
|
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
PART II.
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds*
|
|
|
|
|
|
|
Item 3.
|
Defaults upon Senior Securities*
|
|
|
|
|
|
|
Item 4.
|
Mine Safety Disclosures*
|
|
|
|
|
|
|
Item 5.
|
Other Information*
|
|
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
March 29, 2014
|
|
June 29, 2013
|
||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
2,241
|
|
|
$
|
10,819
|
|
|
Trade receivables, net of allowances of $37 and $40, respectively
|
52,637
|
|
|
47,009
|
|
||
|
Inventories
|
46,086
|
|
|
44,664
|
|
||
|
Deferred income tax asset
|
1,516
|
|
|
1,767
|
|
||
|
Other
|
9,464
|
|
|
7,508
|
|
||
|
Total current assets
|
111,944
|
|
|
111,767
|
|
||
|
Property, plant and equipment—net
|
21,188
|
|
|
17,911
|
|
||
|
Other assets:
|
|
|
|
||||
|
Deferred income tax asset
|
3,052
|
|
|
3,179
|
|
||
|
Other
|
1,914
|
|
|
2,273
|
|
||
|
Goodwill
|
1,740
|
|
|
—
|
|
||
|
Other intangible assets
|
2,138
|
|
|
—
|
|
||
|
Total other assets
|
8,844
|
|
|
5,452
|
|
||
|
Total assets
|
$
|
141,976
|
|
|
$
|
135,130
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
28,540
|
|
|
$
|
26,400
|
|
|
Accrued compensation and vacation
|
6,297
|
|
|
7,413
|
|
||
|
Current portion of other long-term obligations
|
—
|
|
|
576
|
|
||
|
Other
|
5,021
|
|
|
3,551
|
|
||
|
Total current liabilities
|
39,858
|
|
|
37,940
|
|
||
|
Long-term liabilities:
|
|
|
|
||||
|
Deferred income tax liability
|
—
|
|
|
1,585
|
|
||
|
Other long-term obligations
|
564
|
|
|
1,445
|
|
||
|
Total long-term liabilities
|
564
|
|
|
3,030
|
|
||
|
Total liabilities
|
40,422
|
|
|
40,970
|
|
||
|
Commitments and contingencies (Note 8)
|
|
|
|
||||
|
Shareholders’ equity:
|
|
|
|
||||
|
Common stock, no par value—shares authorized 25,000; issued and outstanding 10,533 and 10,502 shares, respectively
|
44,015
|
|
|
43,369
|
|
||
|
Retained earnings
|
55,711
|
|
|
49,478
|
|
||
|
Accumulated other comprehensive income
|
1,828
|
|
|
1,313
|
|
||
|
Total shareholders’ equity
|
101,554
|
|
|
94,160
|
|
||
|
Total liabilities and shareholders’ equity
|
$
|
141,976
|
|
|
$
|
135,130
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
March 29, 2014
|
|
March 30, 2013
|
|
March 29, 2014
|
|
March 30, 2013
|
||||||||
|
Net sales
|
$
|
77,043
|
|
|
$
|
84,343
|
|
|
$
|
233,267
|
|
|
$
|
276,418
|
|
|
Cost of sales
|
70,436
|
|
|
76,483
|
|
|
213,088
|
|
|
249,587
|
|
||||
|
Gross profit
|
6,607
|
|
|
7,860
|
|
|
20,179
|
|
|
26,831
|
|
||||
|
Research, development and engineering expenses
|
1,414
|
|
|
1,329
|
|
|
4,181
|
|
|
3,804
|
|
||||
|
Selling, general and administrative expenses
|
2,985
|
|
|
2,938
|
|
|
8,964
|
|
|
8,406
|
|
||||
|
Total operating expenses
|
4,399
|
|
|
4,267
|
|
|
13,145
|
|
|
12,210
|
|
||||
|
Operating income
|
2,208
|
|
|
3,593
|
|
|
7,034
|
|
|
14,621
|
|
||||
|
Interest expense, net
|
12
|
|
|
38
|
|
|
50
|
|
|
246
|
|
||||
|
Income before income taxes
|
2,196
|
|
|
3,555
|
|
|
6,984
|
|
|
14,375
|
|
||||
|
Income tax provision
|
782
|
|
|
692
|
|
|
751
|
|
|
4,189
|
|
||||
|
Net income
|
$
|
1,414
|
|
|
$
|
2,863
|
|
|
$
|
6,233
|
|
|
$
|
10,186
|
|
|
Net income per share — Basic
|
$
|
0.13
|
|
|
$
|
0.27
|
|
|
$
|
0.59
|
|
|
$
|
0.97
|
|
|
Weighted average shares outstanding — Basic
|
10,533
|
|
|
10,489
|
|
|
10,523
|
|
|
10,488
|
|
||||
|
Net income per share — Diluted
|
$
|
0.13
|
|
|
$
|
0.26
|
|
|
$
|
0.57
|
|
|
$
|
0.94
|
|
|
Weighted average shares outstanding — Diluted
|
10,926
|
|
|
10,931
|
|
|
10,920
|
|
|
10,888
|
|
||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
March 29, 2014
|
|
March 30, 2013
|
|
March 29, 2014
|
|
March 30, 2013
|
||||||||
|
Comprehensive income:
|
|
|
|
|
|
|
|
||||||||
|
Net income
|
$
|
1,414
|
|
|
$
|
2,863
|
|
|
$
|
6,233
|
|
|
$
|
10,186
|
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
||||||||
|
Unrealized gain on foreign exchange contracts, net of tax
|
203
|
|
|
2,458
|
|
|
515
|
|
|
3,481
|
|
||||
|
Comprehensive income
|
$
|
1,617
|
|
|
$
|
5,321
|
|
|
$
|
6,748
|
|
|
$
|
13,667
|
|
|
|
Nine Months Ended
|
||||||
|
|
March 29, 2014
|
|
March 30, 2013
|
||||
|
Operating activities:
|
|
|
|
||||
|
Net income
|
$
|
6,233
|
|
|
$
|
10,186
|
|
|
Adjustments to reconcile net income to cash provided by operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
2,792
|
|
|
1,955
|
|
||
|
Excess tax benefit from exercise of stock options
|
(113
|
)
|
|
(103
|
)
|
||
|
Provision for obsolete inventory
|
227
|
|
|
422
|
|
||
|
Provision for warranty
|
19
|
|
|
16
|
|
||
|
Provision for doubtful accounts
|
37
|
|
|
62
|
|
||
|
Loss on disposal of assets
|
10
|
|
|
27
|
|
||
|
Share-based compensation expense
|
483
|
|
|
647
|
|
||
|
Deferred income taxes
|
(1,532
|
)
|
|
1,495
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Trade receivables
|
(5,665
|
)
|
|
12,212
|
|
||
|
Inventories
|
(872
|
)
|
|
10,274
|
|
||
|
Other assets
|
(1,411
|
)
|
|
(2,199
|
)
|
||
|
Accounts payable
|
2,140
|
|
|
(15,741
|
)
|
||
|
Accrued compensation and vacation
|
(1,116
|
)
|
|
460
|
|
||
|
Other liabilities
|
1,120
|
|
|
1,127
|
|
||
|
Cash provided by operating activities
|
2,352
|
|
|
20,840
|
|
||
|
Investing activities:
|
|
|
|
||||
|
Payment for acquisition
|
(6,027
|
)
|
|
—
|
|
||
|
Proceeds from life insurance
|
—
|
|
|
144
|
|
||
|
Purchase of property and equipment
|
(4,467
|
)
|
|
(2,768
|
)
|
||
|
Cash used in investing activities
|
(10,494
|
)
|
|
(2,624
|
)
|
||
|
Financing activities:
|
|
|
|
||||
|
Payment of financing costs
|
(23
|
)
|
|
(75
|
)
|
||
|
Principal payments on capital lease obligations
|
(576
|
)
|
|
(542
|
)
|
||
|
Borrowings under revolving credit agreement
|
—
|
|
|
66,528
|
|
||
|
Repayment of revolving credit agreement
|
—
|
|
|
(81,539
|
)
|
||
|
Excess tax benefit from exercise of stock options
|
113
|
|
|
103
|
|
||
|
Proceeds from exercise of stock options
|
50
|
|
|
9
|
|
||
|
Cash used in financing activities
|
(436
|
)
|
|
(15,516
|
)
|
||
|
Net (decrease) increase in cash and cash equivalents
|
(8,578
|
)
|
|
2,700
|
|
||
|
Cash and cash equivalents, beginning of period
|
10,819
|
|
|
502
|
|
||
|
Cash and cash equivalents, end of period
|
$
|
2,241
|
|
|
$
|
3,202
|
|
|
Supplemental cash flow information:
|
|
|
|
||||
|
Interest payments
|
$
|
56
|
|
|
$
|
289
|
|
|
Income tax payments, net of refunds
|
$
|
1,850
|
|
|
$
|
1,781
|
|
|
|
Shares
|
|
Common
Stock
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income
|
|
Total
Shareholders’
Equity
|
|||||||||
|
Balances, June 29, 2013
|
10,502
|
|
|
$
|
43,369
|
|
|
$
|
49,478
|
|
|
$
|
1,313
|
|
|
$
|
94,160
|
|
|
Net income
|
—
|
|
|
—
|
|
|
6,233
|
|
|
—
|
|
|
6,233
|
|
||||
|
Unrealized gain on foreign exchange contracts, net
|
—
|
|
|
—
|
|
|
—
|
|
|
515
|
|
|
515
|
|
||||
|
Exercise of stock options
|
31
|
|
|
50
|
|
|
—
|
|
|
—
|
|
|
50
|
|
||||
|
Share-based compensation
|
—
|
|
|
483
|
|
|
—
|
|
|
—
|
|
|
483
|
|
||||
|
Tax benefit from exercise of stock options
|
—
|
|
|
113
|
|
|
—
|
|
|
—
|
|
|
113
|
|
||||
|
Balances, March 29, 2014
|
10,533
|
|
|
$
|
44,015
|
|
|
$
|
55,711
|
|
|
$
|
1,828
|
|
|
$
|
101,554
|
|
|
1.
|
Basis of Presentation
|
|
2.
|
Significant Accounting Policies
|
|
3.
|
Inventories
|
|
|
March 29, 2014
|
|
June 29, 2013
|
||||
|
Finished goods
|
$
|
5,789
|
|
|
$
|
7,097
|
|
|
Work-in-process
|
5,583
|
|
|
5,098
|
|
||
|
Raw materials and supplies
|
34,714
|
|
|
32,469
|
|
||
|
|
$
|
46,086
|
|
|
$
|
44,664
|
|
|
4.
|
|
|
5.
|
Income Taxes
|
|
6.
|
Earnings Per Share
|
|
|
Three Months Ended
|
||||||
|
|
(in thousands, except per share information)
|
||||||
|
|
March 29, 2014
|
|
March 30, 2013
|
||||
|
Net income
|
$
|
1,414
|
|
|
$
|
2,863
|
|
|
Weighted average shares outstanding—basic
|
10,533
|
|
|
10,489
|
|
||
|
Effect of dilutive common stock options
|
393
|
|
|
442
|
|
||
|
Weighted average shares outstanding—diluted
|
10,926
|
|
|
10,931
|
|
||
|
Earnings per share—basic
|
$
|
0.13
|
|
|
$
|
0.27
|
|
|
Earnings per share—diluted
|
$
|
0.13
|
|
|
$
|
0.26
|
|
|
Antidilutive options not included in diluted earnings per share
|
208
|
|
|
—
|
|
||
|
|
Nine Months Ended
|
||||||
|
|
(in thousands, except per share information)
|
||||||
|
|
March 29, 2014
|
|
March 30, 2013
|
||||
|
Net income
|
$
|
6,233
|
|
|
$
|
10,186
|
|
|
Weighted average shares outstanding—basic
|
10,523
|
|
|
10,488
|
|
||
|
Effect of dilutive common stock options
|
397
|
|
|
400
|
|
||
|
Weighted average shares outstanding—diluted
|
10,920
|
|
|
10,888
|
|
||
|
Earnings per share—basic
|
$
|
0.59
|
|
|
$
|
0.97
|
|
|
Earnings per share—diluted
|
$
|
0.57
|
|
|
$
|
0.94
|
|
|
Antidilutive options not included in diluted earnings per share
|
208
|
|
|
—
|
|
||
|
|
July 31, 2013
|
|
July 25, 2012
|
|
January 26, 2012
|
|
July 27, 2011
|
||||||||
|
SARs Granted
|
213,166
|
|
|
210,666
|
|
|
32,000
|
|
|
184,666
|
|
||||
|
Strike Price
|
$
|
11.34
|
|
|
$
|
7.44
|
|
|
$
|
6.30
|
|
|
$
|
4.40
|
|
|
Fair Value
|
$
|
4.67
|
|
|
$
|
3.71
|
|
|
$
|
3.08
|
|
|
$
|
2.20
|
|
|
8.
|
Commitments and Contingencies
|
|
9.
|
Fair Value Measurements
|
|
|
March 29, 2014
|
||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
Fair Value
|
||||||||
|
Financial Assets:
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency forward contracts
|
$
|
—
|
|
|
$
|
2,833
|
|
|
$
|
—
|
|
|
$
|
2,833
|
|
|
Financial Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency forward contracts
|
$
|
—
|
|
|
$
|
(59
|
)
|
|
$
|
—
|
|
|
$
|
(59
|
)
|
|
|
June 29, 2013
|
||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
Fair Value
|
||||||||
|
Financial Assets:
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency forward contracts
|
$
|
—
|
|
|
$
|
2,429
|
|
|
$
|
—
|
|
|
$
|
2,429
|
|
|
Financial Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency forward contracts
|
$
|
—
|
|
|
$
|
(434
|
)
|
|
$
|
—
|
|
|
$
|
(434
|
)
|
|
10.
|
Derivative Financial Instruments
|
|
|
|
|
March 29, 2014
|
|
June 29, 2013
|
||||
|
Derivatives Designated as Hedging Instruments
|
Balance Sheet Location
|
|
Fair Value
|
|
Fair Value
|
||||
|
Foreign currency forward contracts
|
Other current assets
|
|
$
|
2,020
|
|
|
$
|
760
|
|
|
Foreign currency forward contracts
|
Other long-term assets
|
|
$
|
813
|
|
|
$
|
1,669
|
|
|
Foreign currency forward contracts
|
Other current liabilities
|
|
$
|
—
|
|
|
$
|
(145
|
)
|
|
Foreign currency forward contracts
|
Other long-term liabilities
|
|
$
|
(59
|
)
|
|
$
|
(289
|
)
|
|
Derivatives Designated as Hedging Instruments
|
AOCI Balance
as of December 28, 2013 |
|
Effective
Portion
Recorded In
AOCI
|
|
Effective Portion
Reclassified From
AOCI Into
Cost of Sales
|
|
AOCI Balance
as of
March 29,
2014
|
||||||||
|
Settled foreign currency forward contracts for the three months ended March 29, 2014
|
$
|
110
|
|
|
$
|
11
|
|
|
$
|
(121
|
)
|
|
$
|
—
|
|
|
Unsettled foreign currency forward contracts
|
1,515
|
|
|
313
|
|
|
—
|
|
|
1,828
|
|
||||
|
Total
|
$
|
1,625
|
|
|
$
|
324
|
|
|
$
|
(121
|
)
|
|
$
|
1,828
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Derivatives Designated as Hedging Instruments
|
AOCI Balance
as of
December 29,
2012 |
|
Effective
Portion
Recorded In
AOCI
|
|
Effective Portion
Reclassified From
AOCI Into
Cost of Sales
|
|
AOCI Balance
as of March 30,
2013
|
||||||||
|
Settled foreign currency forward contracts for the three months ended March 30, 2013
|
$
|
(9
|
)
|
|
$
|
184
|
|
|
$
|
(175
|
)
|
|
$
|
—
|
|
|
Unsettled foreign currency forward contracts
|
373
|
|
|
2,449
|
|
|
—
|
|
|
2,822
|
|
||||
|
Total
|
$
|
364
|
|
|
$
|
2,633
|
|
|
$
|
(175
|
)
|
|
$
|
2,822
|
|
|
Derivatives Designated as Hedging Instruments
|
AOCI Balance
as of June 29, 2013 |
|
Effective
Portion
Recorded In
AOCI
|
|
Effective Portion
Reclassified From
AOCI Into
Cost of Sales
|
|
AOCI Balance
as of March 29, 2014 |
||||||||
|
Settled foreign currency forward contracts for the nine months ended March 29, 2014
|
$
|
85
|
|
|
$
|
124
|
|
|
$
|
(209
|
)
|
|
$
|
—
|
|
|
Unsettled foreign currency forward contracts
|
1,228
|
|
|
600
|
|
|
—
|
|
|
1,828
|
|
||||
|
Total
|
$
|
1,313
|
|
|
$
|
724
|
|
|
$
|
(209
|
)
|
|
$
|
1,828
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Derivatives Designated as Hedging Instruments
|
AOCI Balance
as of June 30, 2012 |
|
Effective
Portion
Recorded In
AOCI
|
|
Effective Portion
Reclassified From
AOCI Into
Cost of Sales
|
|
AOCI Balance
as of March 30, 2013 |
||||||||
|
Settled foreign currency forward contracts for the nine months ended March 30, 2013
|
$
|
(162
|
)
|
|
$
|
675
|
|
|
$
|
(513
|
)
|
|
$
|
—
|
|
|
Unsettled foreign currency forward contracts
|
(497
|
)
|
|
3,319
|
|
|
—
|
|
|
2,822
|
|
||||
|
Total
|
$
|
(659
|
)
|
|
$
|
3,994
|
|
|
$
|
(513
|
)
|
|
$
|
2,822
|
|
|
|
Fair Values
|
||
|
|
At July 1, 2013
|
||
|
Current Assets
|
$
|
777
|
|
|
Fixed Assets
|
1,168
|
|
|
|
Non-Compete Agreements
|
372
|
|
|
|
Customer Relationships
|
1,970
|
|
|
|
Goodwill
|
1,740
|
|
|
|
Fair value of assets acquired
|
$
|
6,027
|
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
•
|
Inactive, Obsolete, and Surplus Inventory Reserve
|
|
•
|
Allowance for Doubtful Accounts
|
|
•
|
Accrued Warranty
|
|
•
|
Income Taxes
|
|
•
|
Share-Based Compensation
|
|
•
|
Impairment of Long-Lived Assets
|
|
•
|
Derivatives and Hedging Activity
|
|
|
Three Months Ended
|
|||||||||||||||||||
|
|
March 29, 2014
|
|
% of
net sales
|
|
March 30, 2013
|
|
% of
net sales
|
|
$ change
|
|
% point
change
|
|||||||||
|
Net sales
|
$
|
77,043
|
|
|
100.0
|
%
|
|
$
|
84,343
|
|
|
100.0
|
%
|
|
$
|
(7,300
|
)
|
|
—
|
%
|
|
Cost of sales
|
70,436
|
|
|
91.4
|
%
|
|
76,483
|
|
|
90.7
|
%
|
|
(6,047
|
)
|
|
0.7
|
%
|
|||
|
Gross profit
|
6,607
|
|
|
8.6
|
%
|
|
7,860
|
|
|
9.3
|
%
|
|
(1,253
|
)
|
|
(0.7
|
)%
|
|||
|
Research, development and engineering
|
1,414
|
|
|
1.8
|
%
|
|
1,329
|
|
|
1.6
|
%
|
|
85
|
|
|
0.2
|
%
|
|||
|
Selling, general and administrative
|
2,985
|
|
|
3.9
|
%
|
|
2,938
|
|
|
3.5
|
%
|
|
47
|
|
|
0.4
|
%
|
|||
|
Total operating expenses
|
4,399
|
|
|
5.7
|
%
|
|
4,267
|
|
|
5.1
|
%
|
|
132
|
|
|
0.6
|
%
|
|||
|
Operating income
|
2,208
|
|
|
2.9
|
%
|
|
3,593
|
|
|
4.3
|
%
|
|
(1,385
|
)
|
|
(1.4
|
)%
|
|||
|
Interest expense, net
|
12
|
|
|
—
|
%
|
|
38
|
|
|
—
|
%
|
|
(26
|
)
|
|
—
|
%
|
|||
|
Income before income taxes
|
2,196
|
|
|
2.9
|
%
|
|
3,555
|
|
|
4.2
|
%
|
|
(1,359
|
)
|
|
(1.3
|
)%
|
|||
|
Income tax provision
|
782
|
|
|
1.0
|
%
|
|
692
|
|
|
0.8
|
%
|
|
90
|
|
|
0.2
|
%
|
|||
|
Net income
|
$
|
1,414
|
|
|
1.8
|
%
|
|
$
|
2,863
|
|
|
3.4
|
%
|
|
$
|
(1,449
|
)
|
|
(1.6
|
)%
|
|
Effective income tax rate
|
35.6
|
%
|
|
|
|
19.5
|
%
|
|
|
|
|
|
|
|||||||
|
|
Nine Months Ended
|
|||||||||||||||||||
|
|
March 29, 2014
|
|
% of
net sales
|
|
March 30, 2013
|
|
% of
net sales
|
|
$ change
|
|
% point
change
|
|||||||||
|
Net sales
|
$
|
233,267
|
|
|
100.0
|
%
|
|
$
|
276,418
|
|
|
100.0
|
%
|
|
$
|
(43,151
|
)
|
|
—
|
%
|
|
Cost of sales
|
213,088
|
|
|
91.3
|
%
|
|
249,587
|
|
|
90.3
|
%
|
|
(36,499
|
)
|
|
1.0
|
%
|
|||
|
Gross profit
|
20,179
|
|
|
8.7
|
%
|
|
26,831
|
|
|
9.7
|
%
|
|
(6,652
|
)
|
|
(1.0
|
)%
|
|||
|
Research, development and engineering
|
4,181
|
|
|
1.8
|
%
|
|
3,804
|
|
|
1.4
|
%
|
|
377
|
|
|
0.4
|
%
|
|||
|
Selling, general and administrative
|
8,964
|
|
|
3.8
|
%
|
|
8,406
|
|
|
3.0
|
%
|
|
558
|
|
|
0.8
|
%
|
|||
|
Total operating expenses
|
13,145
|
|
|
5.6
|
%
|
|
12,210
|
|
|
4.4
|
%
|
|
935
|
|
|
1.2
|
%
|
|||
|
Operating income
|
7,034
|
|
|
3.0
|
%
|
|
14,621
|
|
|
5.3
|
%
|
|
(7,587
|
)
|
|
(2.3
|
)%
|
|||
|
Interest expense, net
|
50
|
|
|
—
|
%
|
|
246
|
|
|
0.1
|
%
|
|
(196
|
)
|
|
(0.1
|
)%
|
|||
|
Income before income taxes
|
6,984
|
|
|
3.0
|
%
|
|
14,375
|
|
|
5.2
|
%
|
|
(7,391
|
)
|
|
(2.2
|
)%
|
|||
|
Income tax provision
|
751
|
|
|
0.3
|
%
|
|
4,189
|
|
|
1.5
|
%
|
|
(3,438
|
)
|
|
(1.2
|
)%
|
|||
|
Net income
|
$
|
6,233
|
|
|
2.7
|
%
|
|
$
|
10,186
|
|
|
3.7
|
%
|
|
$
|
(3,953
|
)
|
|
(1.0
|
)%
|
|
Effective income tax rate
|
10.8
|
%
|
|
|
|
29.1
|
%
|
|
|
|
|
|
|
|||||||
|
•
|
difficulties in staffing and managing foreign operations;
|
|
•
|
political and economic instability (including acts of terrorism, civil unrest, forms of violence and outbreaks of war), which could impact our ability to ship, manufacture, and/or receive product;
|
|
•
|
unexpected changes in regulatory requirements and laws;
|
|
•
|
longer customer payment cycles and difficulty collecting accounts receivable;
|
|
•
|
export duties, import controls and trade barriers (including quotas);
|
|
•
|
governmental restrictions on the transfer of funds;
|
|
•
|
burdens of complying with a wide variety of foreign laws and labor practices;
|
|
•
|
fluctuations in currency exchange rates, which could affect component costs, local payroll, utility and other expenses;
|
|
•
|
our foreign locations may be impacted by hurricanes, earthquakes, water shortages, tsunamis, floods, typhoons, fires, extreme weather conditions and other natural or man-made disasters.
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
Item 4.
|
Controls and Procedures
|
|
Item 1.
|
Legal Proceedings
|
|
Item 1A.
|
Risk Factors
|
|
Item 6.
|
Exhibits
|
|
|
|
|
|
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer (Exchange Act Rules 13(a)-14 and 15(d)-14)
|
|
|
|
|
|
|
|
31.2
|
|
Certification of Chief Financial Officer (Exchange Act Rules 13(a)-14 and 15(d)-14)
|
|
|
|
|
|
|
|
32.1
|
|
Certification of Chief Executive Officer (18 U.S.C. 1350)
|
|
|
|
|
|
|
|
32.2
|
|
Certification of Chief Financial Officer (18 U.S.C. 1350)
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document *
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document *
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document *
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document *
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document *
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document *
|
|
KEY TRONIC CORPORATION
|
|||
|
|
|
||
|
/s/ C
RAIG
D. G
ATES
|
|
|
|
|
Craig D. Gates
|
|
Date:
|
May 8, 2014
|
|
President and Chief Executive Officer
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
||
|
/s/ R
ONALD
F. K
LAWITTER
|
|
|
|
|
Ronald F. Klawitter
|
|
Date:
|
May 8, 2014
|
|
Executive Vice President of Administration, Chief Financial Officer and Treasurer
|
|
|
|
|
(Principal Financial Officer)
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|